04/24/2024 3:20 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/18/2024 4:23 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/18/2024 4:25 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:40 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:37 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/16/2024 6:10 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 3:15 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
04/02/2024 3:15 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 4:15 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2024 7:44 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 7:31 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:31 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:32 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:33 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:33 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:52 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:38 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:45 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:30 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:30 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 4:58 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:58 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:58 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:59 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:59 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 3:44 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024 3:36 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024 3:27 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 6:04 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:41 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:57 PM | Intra-Cellular Therapies (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:58 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:58 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:59 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 7:00 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 7:00 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 3:22 PM | Intra-Cellular Therapies (Subject) VAN NOSTRAND ROBERT L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:46 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad) The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%...
Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 |
02/26/2024 3:46 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:33 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:22 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024 6:39 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 6:42 AM | Intra-Cellular Therapies (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/09/2024 11:40 AM | Intra-Cellular Therapies (Subject) WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/05/2024 5:02 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:05 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:07 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:10 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:13 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:47 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 3:39 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 3:41 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 6:47 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 4:08 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 5:02 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 3:45 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 6:54 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 5:43 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 5:46 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:38 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 10:15 AM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:52 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023 4:31 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 3:15 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023 12:06 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 7:01 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 7:01 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2023 4:29 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 4:30 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 7:40 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 3:13 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023 3:13 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:18 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 3:40 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023 5:05 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 5:09 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023 6:39 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 6:44 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/20/2023 4:47 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2023 3:13 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/07/2023 5:07 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4/A | |
07/07/2023 5:07 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4/A | |
07/07/2023 5:08 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4/A | |
07/05/2023 3:30 PM | Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2023 3:30 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:11 PM | Intra-Cellular Therapies (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:11 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:12 PM | Intra-Cellular Therapies (Issuer) Salas Eduardo Rene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
06/27/2023 4:12 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 4:05 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 3:28 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/04/2023 6:45 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023 6:37 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |